Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent Systems
Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving averages, with a decisive close above 24,200 crucial for further gains. Several companies like Waaree Energies, Kotak Bank, and Tata Motors are in focus due to significant developments, including US investigations, strategic partnerships, and EV expansion plans.
Welcome To The Jungle Box Office Collection Day 3: Akshay Kumar's Star-Studded Comedy Sees Healthy Response
Welcome To The Jungle opened to a decent response and benefited from its franchise value, star-studded cast and family-friendly appeal.
Strides Pharma sells majority stake in arm Pivot Path for Rs 100 crore
Strides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital and Vintage Classic. This strategic move aims to accelerate Pivot Path's growth by infusing Rs 50 crore for future expansion. Strides will retain a 19.95% stake, while the investors will hold 65.05%. The transaction values Pivot Path at Rs 230 crore post-money.
Strides Pharma to monetise stake in Pivot Path; company valued at ₹230 crore post-money
Strides Pharma Science Limited will monetise its stake in subsidiary Pivot Path Private Limited in a transaction led by Ascent Capital, alongside co-investor Vintage Classic, valuing the entity at near ₹230 crore post-money. The company will realise near ₹100 crore while retaining near 20% ownership and also receive a primary capital infusion of ₹50 crore into the business.
FIFA World Cup 2026: Endrick-Ancelotti Memes Explode On Internet. Here's why
The alleged d rift between Brazil coach Carlo Ancelotti and teenage star Endrick has sparked a viral meme frenzy, overshadowing even the team's remarkable on-field exploits at the FIFA World Cup 2026.
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition in under a year, signals a growing trend of consolidation in the beauty and personal care sector. Honasa aims to integrate science-backed skincare with nutraceuticals, addressing consumer demand for holistic wellness solutions. Fluence Pharma will become the ninth brand under Honasa's umbrella.
Promoter Twin Star sells Vedanta shares worth Rs 1,896 crore in block deal
Twin Star Holdings, a promoter entity of Vedanta, sold 6.51 crore shares worth nearly Rs 1,896 crore through a block deal on Tuesday. The transaction comes amid Vedanta's ongoing restructuring efforts following the listing of its demerged businesses and continued focus on debt reduction and value unlocking.
Adani Mundra Airport launches first scheduled flight services
Adani Mundra Airport has launched its first scheduled flight service with Star Air, connecting Mundra to Mumbai and Goa. This expansion includes eight new routes, significantly boosting connectivity for businesses, trade, and tourism in the Kutch region. The airport's new operations are a key step in developing Kutch into a comprehensive logistics and business hub, adding another vital transport option for commercial activities.
New India Assurance, Star Health, CDSL surge amid spike in trading activity; check full list - Upstox
New India Assurance, Star Health, CDSL surge amid spike in trading activity; check full listUpstox
New India Assurance Company Ltd leads gainers in 'A' group
Galaxy Surfactants Ltd, Star Health & Allied Insurance Company Ltd, FSN E-Commerce Ventures Ltd and R R Kabel Ltd are among the other gainers in the BSE's 'A' group today, 18 June 2026.
JM Fin on insurance: Retail health to drive growth; Star Health top pick
The brokerage said that it prefers Star Health in the space as it has recommended a 'Buy' rating on the stock for a target price of ₹650.
Blue Star: Nirmal Bang Maintains Buy on Strong Fundamentals, Long-Term Growth Drivers— Check Target Price
Blue Star's shares are likely to be in focus after Nirmal Bang reiterated its Buy' rating on the stock, citing strong fundamentals and long-term growth visibility.